1![Contrast enhancement in MR imaging: New options, new techniques, new opportunities Nephrogenic systemic fibrosis update 2014: Fact versus theory Emanuel Kanal, MD, FACR, FISMRM Contrast enhancement in MR imaging: New options, new techniques, new opportunities Nephrogenic systemic fibrosis update 2014: Fact versus theory Emanuel Kanal, MD, FACR, FISMRM](https://www.pdfsearch.io/img/6e701d88028c5c708fbf9e7084e260cd.jpg) | Add to Reading ListSource URL: cdn.agilitycms.comLanguage: English - Date: 2015-05-13 14:14:19
|
---|
2![[removed] ® HIGHLIGHTS OF PRESCRIBING INFORMATION [removed] ® HIGHLIGHTS OF PRESCRIBING INFORMATION](https://www.pdfsearch.io/img/b7ed40de17a3cdfd331c3ac02e524cab.jpg) | Add to Reading ListSource URL: www.lantheus.comLanguage: English - Date: 2014-01-01 15:09:52
|
---|
3![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OMNISCAN safely and effectively. See full prescribing information for OMNISCAN. OMNISCANTM (gadodiamide) Injection f HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OMNISCAN safely and effectively. See full prescribing information for OMNISCAN. OMNISCANTM (gadodiamide) Injection f](https://www.pdfsearch.io/img/de277852f2f77dbcf5fc13035345bbdc.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2014-11-17 14:53:23
|
---|
4![OPTIMARK (gadoversetamide) injection Label OPTIMARK (gadoversetamide) injection Label](https://www.pdfsearch.io/img/d4e7493e2fa953a324c6f2f32e614967.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2014-11-25 11:08:36
|
---|
5![FDA Patient Safety News: Show #54, August 2006 FDA Patient Safety News: Show #54, August 2006](https://www.pdfsearch.io/img/a0a28b221863d4269f58f51d9959d266.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
6![Omniscan (gadodiamide) injection label Omniscan (gadodiamide) injection label](https://www.pdfsearch.io/img/b5bbd043a0f088886517c3006d334a95.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2010-12-21 14:44:58
|
---|
7![Prohance (gadoteridol) injection label Prohance (gadoteridol) injection label](https://www.pdfsearch.io/img/2b6cf59e457c67454eedb23274725f5c.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2010-12-21 14:29:00
|
---|
8![Public Assessment Report for paediatric studies submitted in accordance with Article 45 and 46 of Regulation (EC) No1901/2006, as amended Gadopentetic acid (Gadopentate) Magnevist Public Assessment Report for paediatric studies submitted in accordance with Article 45 and 46 of Regulation (EC) No1901/2006, as amended Gadopentetic acid (Gadopentate) Magnevist](https://www.pdfsearch.io/img/c76d48747274a74e1332537007bb03c2.jpg) | Add to Reading ListSource URL: www.hma.euLanguage: English - Date: 2014-04-01 10:51:04
|
---|
9![Microsoft Word - 2-New Omniscan_ACM_Brief_ver5.doc Microsoft Word - 2-New Omniscan_ACM_Brief_ver5.doc](https://www.pdfsearch.io/img/16e338216baf254c0dc2ad3a2f5b8916.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
10![U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived](https://www.pdfsearch.io/img/8dc5ce18a10a698559638827b4891c63.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|